Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
132.50
+1.00 (0.76%)
Oct 16, 2026, 1:30 PM CST
TPEX:3218 Market Cap
TPEX:3218 has a market cap or net worth of 11.23 billion as of October 16, 2026. It is the 17,305th most valuable company in the world and the 683rd biggest in Taiwan. Its market cap has decreased by 6.69% in one year.
Market Cap
11.23B
Enterprise Value
11.73B
Revenue
4.27B
Global Rank
Country Rank
#683 Taiwan
PE Ratio
9.85
ChartMarket Cap Chart
Since November 3, 2008, TPEX:3218's market cap has increased from 1.01B to 11.23B, an increase of 1,016.55%. That is a compound annual growth rate of 14.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 11.23B | -9.25% |
| Dec 31, 2025 | 12.37B | -27.00% |
| Dec 31, 2024 | 16.94B | -27.80% |
| Dec 29, 2023 | 23.47B | -1.63% |
| Dec 30, 2022 | 23.86B | 10.75% |
| Dec 30, 2021 | 21.54B | 18.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 515.97B |
| Lin BioScience | 137.65B |
| Caliway Biopharmaceuticals | 119.61B |
| Heron Neutron Medical | 71.57B |
| Lumosa Therapeutics | 12.71B |
| Foresee Pharmaceuticals | 12.23B |
| Vizionfocus | 12.16B |
| AP Biosciences | 11.90B |